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Abstract
Insulin-like signalling is a conserved mechanism that coordinates animal growth and metabolism with nutrient status. In
Drosophila, insulin-producing median neurosecretory cells (IPCs) regulate larval growth by secreting insulin-like peptides
(dILPs) in a diet-dependent manner. Previous studies have shown that nutrition affects dILP secretion through humoral
signals derived from the fat body. Here we uncover a novel mechanism that operates cell autonomously in the IPCs to
regulate dILP secretion. We observed that impairment of ribosome biogenesis specifically in the IPCs strongly inhibits dILP
secretion, which consequently leads to reduced body size and a delay in larval development. This response is dependent on
p53, a known surveillance factor for ribosome biogenesis. A downstream effector of this growth inhibitory response is an
atypical MAP kinase ERK7 (ERK8/MAPK15), which is upregulated in the IPCs following impaired ribosome biogenesis as well
as starvation. We show that ERK7 is sufficient and essential to inhibit dILP secretion upon impaired ribosome biogenesis,
and it acts epistatically to p53. Moreover, we provide evidence that p53 and ERK7 contribute to the inhibition of dILP
secretion upon starvation. Thus, we conclude that a cell autonomous ribosome surveillance response, which leads to
upregulation of ERK7, inhibits dILP secretion to impede tissue growth under limiting dietary conditions.
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Introduction
Animals coordinate tissue growth and body size with changing
nutrient conditions and it is well established that insulin-like
signalling has a key role in this process [1,2]. In mammals, insulin-
like signalling is mediated by insulin and insulin-like growth factors
through their respective receptors. Drosophila possesses a single
insulin-like receptor, which is activated by insulin-like peptides
(dILPs). There are currently eight dILPs identified in Drosophila
and several of them (e.g. dILP2, -3 and -5) are mainly expressed
and secreted by a group of 14 median neurosecretory cells, also
known as insulin-producing cells (IPCs) [3,4]. These cells are
critical in controlling organismal growth, as disturbance of IPC
function leads to strongly reduced body size [4]. IPC function is
coupled to nutrient status as starvation of Drosophila larvae leads
to inhibition of dILP secretion [5]. Recent studies have
demonstrated that fat body, the insect counterpart of adipose
tissue and liver, senses nutrient status and regulates dILP secretion
by hormonal mechanisms [5,6]. Secreted fat body cytokine
Unpaired 2 is regulated by dietary sugars and lipids and it
controls a population of GABAergic neurons in the brain that
project onto IPCs. Upd2 activates the JAK-STAT pathway in
these neurons, which relieves the inhibitory effect of GABAergic
neurons on IPCs, resulting in dILP secretion [6]. Moreover, the fat
body senses amino acid levels and in turn secretes an unknown
humoral signal, which facilitates dILP secretion from the IPCs [5].
Recently, it was shown that adiponectin receptor also regulates
dILP secretion from the IPCs, but the corresponding ligand is not
yet identified [7]. Beyond these examples, the regulation of IPC
function in response to changing nutrient status is poorly
understood. In particular, very little is known of how cell intrinsic
pathways within the IPCs affect dILP secretion, and consequently
organismal growth.
Ribosome biogenesis is a major consumer of cellular energy and
a key determinant of cell growth capacity [8]. Ribosome
biogenesis is tightly regulated by nutrient, growth factor and stress
responsive signalling networks [1,8–13]. As the ribosome biogen-
esis pathway is a major integrator of growth regulatory signals, its
activity needs to be closely monitored. p53 serves as one of the
ribosome biogenesis surveillance factors [14]. Impaired ribosome
biogenesis activates p53, likely through several parallel mecha-
nisms. For example, imbalance of ribosomal components allows
ribosomal proteins RPL5 and RPL11 in complex with 5S rRNA to
inhibit HDM2/MDM2-dependent degradation of p53 [15–17].
On the other hand, nucleolar Myb binding protein 1A
(MYBBP1A) translocates to the nucleoplasm if rRNA production
is inhibited [18]. Nucleoplasmic MYBBP1A increases p53 activity
by promoting its tetramerization and acetylation [19]. In
proliferating cells, activation of p53 through these mechanisms
leads to cell cycle arrest [16]. However, the role of ribosome
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biogenesis surveillance in other physiological settings is poorly
understood. This is a relevant question, as disturbed ribosome
biogenesis is known to have highly tissue-specific consequences in
vivo. In humans, mutations in ribosomal components or other
ribosome biogenesis genes lead to genetic disorders called
ribosomopathies [20]. They manifest, for example, as bone
marrow failure, anemia, skin abnormalities, and pancreatic
insufficiency [20]. In Drosophila, mutations that disturb ribosome
biogenesis lead to so-called Minute phenotype, displaying
impaired growth, poor fertility and short and thin bristles [21].
Inhibition of ribosome biogenesis specifically in the Drosophila fat
body or prothoracic gland influences systemic growth by affecting
hormonal regulation through insulin and ecdysone signalling axes,
respectively [22–24]. Which signalling mechanisms mediate the
distinct cell type-specific phenotypes of ribosome surveillance in
vivo is, however, poorly understood.
Here we report that dILP secretion is tightly coupled to the
activity of the ribosome biogenesis pathway within the IPCs. We
show that the p53 dependent ribosomal surveillance response
inhibits dILP secretion and identify atypical MAP kinase ERK7
as a downstream effector of the ribosome surveillance response
in this setting. Furthermore, we provide evidence that both p53
and ERK7 activities within the IPCs contribute to regulation of
dILP secretion in response to nutrient status. Thus, we propose
that the p53- and ERK7-dependent ribosome surveillance
pathway serves as a local branch of the IPC-regulating nutrient
sensing network, parallel to the humoral signals derived from
the fat body.
Results
Kinome-wide screen identifies novel regulators of IPC
function
While the role of Drosophila insulin-like peptides (dILPs) in
systemic growth control is well established, it remains poorly
understood how the secretion of dILPs is regulated in response
to changing dietary conditions. To get a better insight into this
question, we explored the cell autonomous signalling mecha-
nisms that regulate dILP secretion, by performing a kinome-
wide screen with RNAi expressed specifically in the IPCs.
Impaired IPC function compromises tissue growth [4] and
therefore we used body weight of emerging adults as a
screening readout (Figure 1A, Table S1). To normalize
variation between vials due to growth conditions, we deter-
mined the relative weight wherein the mean weight of the flies
expressing both dILP2-Gal4 and RNAi was divided by the
mean weight of control flies (not expressing the dILP2-Gal4)
from the same vial. In total, 231 kinases were screened. All
primary hits displaying .10% difference to the median relative
weight were further analyzed by an independent RNAi line.
Altogether 12 protein kinases showed significant body weight
reduction in two independent RNAi lines (Figure 1B). All
identified kinases have mammalian orthologs (Table 1). In
addition to these 12 kinases identified here, we have earlier
shown that atypical PKC is essential for IPC function [25].
One of the kinase hits was TOR (target of rapamycin). TOR
kinase is present in two functionally distinct complexes, TOR
complex 1 and 2 (TORC1 and TORC2). To explore which of
the TOR complexes have a regulatory role in the IPCs, we
depleted Raptor and Rictor, essential components of TORC1
and TORC2, respectively. Knockdown of Raptor in the IPCs
significantly reduced total body weight, while depletion of
Rictor had no significant impact (Figure 1C), showing that
TORC1 regulates growth through the IPCs. However, as
RNAi does not completely silence gene expression, we cannot
rule out the involvement of TORC2.
To explore gene expression of three IPC-expressed dilp genes,
namely dilp2, dilp3 and dilp5, we analyzed RNA from larval
brains by quantitative RT-PCR (Figure 1D). In the case of most
hits, expression of dilp2 and dilp5 remained nearly unchanged.
In contrast, dilp3 expression was elevated in several samples. This
is likely due to a feedback mechanism activated by reduced
autocrine insulin signalling in the IPCs [26]. Only depletion of
Tousled-like kinase (Tlk) significantly reduced dilp3 expression
(Figure 1D).
Disturbed ribosome biogenesis in the IPCs inhibits dILP
secretion
Secretion of dILPs is a key regulatory level in determining the
activity of systemic insulin signalling [5]. dILP2 contributes to the
total body weight [26] and its secretion can be assessed by
monitoring its accumulation into the cell bodies of IPCs.
Accumulation is observed when dILP2 secretion is inhibited upon
starvation [5]; (Figure 2A, B). Of the hits, 5 kinases caused
significant dILP2 accumulation upon knockdown. These include
Cdk12, Adck (CG3608), Pkc98E (Figure S1), as well as two Rio
kinases, Rio1 and Rio2 (Figure 2A, B). Rio1 and Rio2 belong to a
group of atypical kinases and they have a conserved role in
ribosome maturation [27–30]. As ribosome biogenesis is a process
tightly coupled to nutrient sensing [1,12], we chose to further
explore the role of Rio kinases in dILP secretion. We confirmed
that, similarly to starvation, IPC-specific depletion of Rio kinases
led to elevated insulin-like receptor (inr) gene expression in the
larva (Figure 2C), which is an established readout for reduced
peripheral insulin signalling [31]. If the inhibition of dILP2
secretion was due to impaired ribosome biogenesis, we predicted
that depletion of other ribosomal genes would phenocopy this
effect. Indeed, IPC-specific knockdown of a number of other
ribosomal components or genes involved in various steps of
ribosome biogenesis led to significantly reduced body size
(Figure 2D). To further confirm that the dILP2 secretion
phenotypes of Rio kinases were due to impaired ribosome
Author Summary
Ribosome biogenesis is a major consumer of cellular
energy and a rate-limiting process during cell growth. The
ribosome biogenesis pathway is tightly connected with
signaling pathways that regulate tissue growth. For
example, nutrient-regulated signaling cues adjust the rate
of ribosome biogenesis. On the other hand, the process of
ribosome biogenesis is closely monitored by so-called
surveillance mechanisms. The best-known ribosome sur-
veillance factor is the transcription factor and tumor
suppressor p53. In proliferating cells, activation of p53
upon disturbed ribosome biogenesis leads to cell cycle
arrest and inhibition of proliferation. Here we show that
ribosome surveillance not only regulates growth locally in
proliferating cells, but is also coupled to hormonal growth
control through regulation of insulin like peptide (dILPs)
secretion. We observed that inhibition of ribosome
biogenesis in the Drosophila insulin-producing cells gen-
erates a strong cell autonomous signal to inhibit dILP
secretion. We identify two downstream effectors of this
ribosome surveillance response by showing that p53 as
well as an atypical MAP kinase ERK7 are mediators of the
inhibition of dILP secretion. We also provide evidence that
this ribosome surveillance mechanism contributes to
nutrient-dependent regulation of dILP secretion.
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Figure 1. Kinome-wide screen identifies novel regulators of IPCs. (A) Overview of the kinome-wide RNAi screen in the IPCs. Each point
indicates the mean body weight of RNAi expressing flies normalized to weight of flies from the same vial that do not express RNAi in the IPCs (i.e.
relative weight). Dotted lines indicate +/210% of the median body weight. (B) Kinome-wide RNAi screen identifies 12 kinases whose knockdown in
the IPCs by two independent RNAi lines leads to significantly reduced body weight. Error bars represent standard deviation (N$3, $10 flies/group).
(C) TORC1 is essential for normal IPC function. Knockdown of Raptor, but not Rictor, in IPCs leads to reduction in body weight. Error bars represent
standard deviation (N= 4,$10 flies/group). (D) Relative mRNA expression of dilp2, dilp3, and dilp5 upon knockdown of the kinase hits. Knockdown of
Raptor, instead of TOR, was used to inhibit TORC1 function. Error bars represent standard deviation (N= 3, 10 brains/group). GAPDH was used as an
internal reference. *p,0.05, **p,0.01, ***p,0.001 (Student’s t-test).
doi:10.1371/journal.pgen.1004764.g001
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biogenesis, we depleted ribosomal protein Rpl35A and ribosome
assembly factor Tsr1 (CG7338) in the IPCs and observed a similar
inhibition of dILP2 secretion in both cases (Figure 2E, F). The
dILP2-Gal4 driver we used [4] displays activity in the salivary
glands, in addition to IPCs. Depletion of Rio2 by a salivary gland
specific Sgs3-Gal4 driver [32] caused no growth reduction, ruling
out the possibility of nonspecific effects through the salivary glands
(Figure S2).
TORC1 signalling regulates ribosome biogenesis gene
expression in Drosophila in a context-dependent manner. In
S2 cells, expression of ribosome biogenesis genes is TORC1-
dependent [33,34], while in the context of whole larvae, TOR
mutants do not display significantly reduced expression of
ribosome biogenesis genes [35]. In accordance with the earlier
observations in whole larvae, inhibition of Raptor in the IPCs
did not lead to inhibited dILP2 secretion (Figure S3).
Transcription factor dMyc is a conserved master regulator of
ribosome biogenesis [13,36]. It transcriptionally regulates the
expression of rRNAs as well as ribosomal proteins [36]. In
Drosophila larvae ribosome biogenesis genes that are inhibited
upon starvation are targets of dMyc [35]. Therefore we tested
whether dMyc activity in the IPCs has an impact on dILP2
secretion. Indeed, RNAi-mediated depletion of dMyc promi-
nently inhibited dILP2 secretion (Figure 2G, H) and led to
reduced body weight (Figure 2I).
We wanted to further explore whether inhibition of ribosome
biogenesis affects the secretion of other dILPs in the IPCs.
Similarly to dILP2, secretion of dILP5 was inhibited upon Rio2
knockdown (Figure 2J, K). Inhibition of systemic growth often
manifests as prolonged larval development, in addition to reduced
body size. Indeed, depletion of Rio2 in the IPCs led to significant
delay in pupation kinetics (Figure 2L). In conclusion, inhibition of
ribosome biogenesis in the IPCs triggers a response that blocks
dILP secretion and consequently leads to slower larval develop-
ment and reduced body size.
p53 mediates dILP2 accumulation upon inhibited
ribosome biogenesis
How is the ribosome biogenesis pathway coupled to dILP
secretion? We hypothesised that one of the ribosome biogenesis
surveillance pathways might link secretion to the status of
ribosome biogenesis in specialised secretory cells like the IPCs.
As p53 is the best-established surveillance factor for the ribosome
biogenesis pathway [14,15,37], we wanted to explore, whether it is
involved in the regulation of dILP secretion. Indeed, overexpres-
sion of p53 in the IPCs revealed that p53 is sufficient to cause
dILP2 accumulation (Figure 3A, B). To analyse the possible
impact of transcriptional regulation, we measured dilp2 mRNA
levels by quantitative RT-PCR. p53 overexpression caused modest
downregulation of dilp2 mRNA levels (Figure S4), ruling out the
possibility of transcriptional activation as a cause for p53-
dependent dILP2 accumulation. To assess the contribution of
p53-mediated dILP regulation on growth, we analyzed pupal
volume, which is a sensitive means to measure changes in total
body size [22]. In our hands, pupal volume data is consistent with
the adult weight, but displays less random variation. In accordance
with the immunofluorescence data suggesting inhibited dILP2
secretion, p53 overexpression in the IPCs strongly reduced the
pupal volume (Figure 3C). In contrast, overexpression of p53 in
the salivary glands caused no growth impairment (Figure S2). In
sum, our data is consistent with the idea that p53 expression in the
IPCs is sufficient to prevent dILP secretion and consequently
inhibit tissue growth.
Next, we wanted to explore, whether the p53 would mediate the
observed inhibition of dILP2 secretion upon disturbed ribosome
biogenesis. This was the case, as depletion of p53 rescued the
Table 1. Brief descriptions of the confirmed hits and their mammalian homologs.
Gene CG number Mammalian homolog Brief description
Rio2 CG11859 RIO2/RIOK2 Rio kinase 2; required for processing of 18S rRNA and maturation of 40S ribosomal
subunit.
Rio1 CG11660 RIO1/RIOK1 Rio kinase 1; required for processing of 18S rRNA and maturation of 40S ribosomal
subunit.
Dsor1/d-MEK CG15793 MAP2K1 Mitogen-activated protein kinase kinase 1; activates ERK1/2 MAP kinases.
Pdk1 CG1210 PDPK1 3-phosphoinositide dependent protein kinase-1; phosphorylates the activation loop of
many AGC kinases, including AKT, S6K, and PKC.
Cdk12 CG7597 CDK12 Cyclin-dependent kinase 12; transcription elongation-associated CTD kinase. Involved
in cell cycle, maintenance of genome stability and in RNA splicing.
Trc CG8637 STK38 Serine/threonine kinase 38; controls cell structure and proliferation of a variety of
polarized outgrowths.
Adck CG3608 ADCK1 aarF domain containing kinase 1; mitochondrial protein, might be involved in
coenzyme Q (10) biosynthesis.
Pkc98E CG1954 PKCE Protein kinase C, epsilon; calcium-independent, phospholipid and diacylglycerol-
dependent, serine- and threonine-specific kinase with many functions.
Tlk CG34412 TLK1 Tousled-like kinase 1; regulates chromatin dynamics, DNA replication and repair,
transcription, chromosome segregation.
Drak CG32666 DRAK1/STK17A Serine/threonine kinase 17a; regulates cytoskeletal dynamics and morphogenesis.
Tor CG5092 mTOR Mechanistic target of rapamycin (serine/threonine kinase); kinase subunit of both
mTORC1 and mTORC2, regulates cell growth and metabolism in response to nutrient
and hormonal signals.
Btl CG32134 FGFR2 Fibroblast growth factor receptor 2; regulates many developmental processes,
including branching morphogenesis.
doi:10.1371/journal.pgen.1004764.t001
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dILP2 accumulation upon Rio2 knockdown (Figure 3D, E) along
with partial rescue of the growth impairment (Figure 3F). A similar
rescue of growth was observed when p53 was depleted in
combination with Rio1 (Figure S5). Moreover, a control RNAi
targeting firefly Luciferase, but no endogenous genes, had no
influence on the phenotypes of Rio2 RNAi in the IPCs (Figure S6),
demonstrating that expression of an additional RNAi does not
interfere with Rio2 RNAi activity.
Figure 2. Disturbed ribosome biogenesis in the IPCs inhibits dILP secretion. (A) Starvation or disturbed ribosome biogenesis by
knockdown of Rio1 or Rio2 leads to accumulation of dILP2 in cell bodies of IPCs. (B) Quantification of the immunofluorescence from Fig. 2A. Error
bars represent standard deviation (N$10) (C) Relative mRNA expression of inr in whole larvae is elevated upon starvation or knockdown of Rio1 or
Rio2 in the IPCs. Error bars represent standard deviation (N= 3, $5 larvae/group). cdk7 was used as an internal reference. (D) IPC-specific knockdown
of ribosomal components or genes involved in ribosome biogenesis leads to reduction of body weight. Error bars represent standard deviation (N$3,
$10 flies/group). (E, F) Knockdown of Rpl35A or Tsr1 inhibits dILP2 secretion from IPCs. Error bars represent standard deviation (N$10). (G, H)
Depletion of dMyc in the IPCs leads to accumulation of dILP2. Error bars represent standard deviation (N$10). (I) dMyc knockdown in the IPCs leads
to reduced body weight. Error bars represent standard deviation (N$3,$10 flies/group). (J, K) Depletion of Rio2 in the IPCs leads to accumulation of
dILP5. Error bars represent standard deviation (N$10). (L) Rio2 knockdown in the IPCs leads to delay in pupation. Error bars represent standard
deviation (N= 4, 30 larvae/group). For all confocal images, IPCs are labelled by GFP (green) and dILP2 or dILP5 is shown as red. *p,0.05, **p,0.01,
***p,0.001 (Student’s t-test).
doi:10.1371/journal.pgen.1004764.g002
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ERK7 mediates the inhibition of dILP secretion upon
impaired ribosome biogenesis
Identification of p53 as an essential inhibitor of dILP2 secretion
implied that ribosome biogenesis regulates dILP secretion through
an active surveillance mechanism, rather than through an indirect
mechanism following reduced translation. To directly couple
ribosome surveillance to secretion we turned our attention to
known regulators of the secretory pathway. It was recently shown
that an atypical MAP kinase called ERK7 (also known as ERK8 or
MAPK15) inhibits secretion upon serum and amino acid
starvation in Drosophila S2 cells [38]. ERK7 was shown to
phosphorylate Sec16 and thus prevent its recruitment to ER exit
sites, consequently preventing the export of the secretory cargo.
Therefore, we wanted to explore, whether ERK7 is regulated in
response to inhibited ribosome biogenesis. In order to do so, we
used in situ hybridization of larval brain. erk7 expression was
undetectable in fed control larvae, whereas overexpression of
transgenic ERK7 by dILP2-Gal4 led to a strong IPC-specific
signal (Figure S7). As a negative control we used an erk7 sense
probe for the ERK7 overexpressing samples (Figure S7). After
confirming the specificity of the in situ hybridization, we analysed
erk7 expression upon disturbed ribosome biogenesis. Intriguingly,
we observed that erk7 mRNA levels were clearly elevated in the
IPCs following Rio2 depletion using dILP2-Gal4 (Figure 4A),
implying that ERK7 is upregulated upon ribosome surveillance in
the IPCs. As ribosome biogenesis is inhibited upon starvation [35],
we hypothesized that starvation might also cause elevated
expression of erk7, which indeed was the case (Figure 4A).
Notably, in the context of brain tissue, the starvation-induced
upregulation appeared specific to the IPCs, since erk7 mRNA
remained undetectable in other brain areas. To confirm the
regulation of erk7 mRNA by an independent method, we used
quantitative RT-PCR on mRNA samples isolated from whole
larvae. Disturbance of ribosome biogenesis by ubiquitous deple-
tion of Rio1, Rio2 and Myc led to elevated erk7 expression
(Figure 4B, C). Similarly, starvation caused significant upregula-
tion of erk7 mRNA levels in the whole larval samples (Figure 4D).
In sum, our data shows that erk7 gene expression is elevated upon
impaired ribosome biogenesis and starvation, suggesting a possible
role for ERK7 in the regulation of dILP secretion during these
conditions.
To this end, we decided to explore the functional relationship
between ribosome surveillance, ERK7 and dILP secretion in the
IPCs. We analyzed transgenic flies that specifically overexpress
ERK7 in the IPCs (Figure S7). Indeed, ERK7 overexpression led
to prominent accumulation of dILP2 and dILP5 in the IPCs
(Figure 5A–5D). Consistently, ERK7 overexpression in the IPCs,
but not in salivary glands, led to reduced pupal volume (Figure 5E
and Figure S2) as well as delayed pupation (Figure 5F). To rule out
the possibility that the ERK7-dependent dILP accumulation was
due to elevated transcription, we used quantitative RT-PCR to
measure dilp2 and dilp5 mRNA levels, which remained
unchanged upon ERK7 overexpression (Figure S8). Thus, we
conclude that elevated ERK7 expression is sufficient to inhibit
dILP secretion cell autonomously in the IPCs. We also performed
genetic epistasis experiments to test if ERK7 is essential to inhibit
dILP2 secretion upon disturbed ribosome biogenesis. Indeed,
ERK7 RNAi efficiently suppressed the dILP2 accumulation
caused by Rio2 knockdown (Figure 5G, H). Similar suppression
was observed in the case of dILP2 accumulation following dMyc
depletion (Figure S9). Consistent with the effects on dILP2
secretion, IPC-specific depletion of ERK7 partially suppressed the
impaired growth upon knockdown of Rio2, while having no effect
on body size in the wild type background (Figure 5I).
Figure 3. p53 mediates dILP2 accumulation upon inhibited ribosome biogenesis. (A, B) Overexpression of p53 in the IPCs is sufficient to
inhibit dILP2 secretion. Error bars represent standard deviation, (N$10 brains). (C) Overexpression of p53 in the IPCs leads to reduced pupal volume.
Error bars represent standard deviation, (N = 3, 10 pupae/group). (D, E) Knockdown of p53 suppresses dILP2 accumulation following Rio2 depletion.
Error bars represent standard deviation, (N$10 brains). (F) Knockdown of p53 leads to partial rescue of pupal volume phenotype observed upon Rio2
depletion. Error bars represent standard deviation, (N = 3, 10 pupae/group). For all confocal images, IPCs are marked by GFP (green) and dILP2 is
shown as red. **p,0.01, ***p,0.001 (Student’s t-test).
doi:10.1371/journal.pgen.1004764.g003
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ERK7 acts downstream of p53 in nutrient responsive
regulation of dILP2 secretion
As we had observed that both p53 and ERK7 were essential for
the inhibition of dILP2 secretion upon impaired ribosome
biogenesis, we wanted to explore whether they belong to the same
pathway. We hypothesized that ERK7 might be a downstream
effector of p53. Supporting this idea, we observed that overexpres-
sion of wild type p53 in the IPCs led to elevated expression of erk7
mRNA as detected by in situ hybridization (Figure 6A). To further
test the possible relevance of the p53-mediated regulation of erk7 in
the IPCs, we performed genetic epistasis experiments. Indeed,
depletion of ERK7 efficiently suppressed the dILP2 accumulation
upon p53 overexpression (Figure 6B, C). Consistently, ERK7RNAi
also partially suppressed the reduction of pupal volume caused by
p53 overexpression (Figure 6D) along with the delay in pupation
(Figure 6E). Notably, the suppression by ERK7 RNAi was only
partial, leaving open the possibility for a parallel, ERK7-indepen-
dent, mechanism. In sum, our data implies that p53 and ERK7
belong to the same pathway and ERK7 acts as a downstream
effector of p53 in inhibiting dILP2 secretion.
As ribosome biogenesis is dependent on nutrients [1,12,35], and
erk7 expression was elevated upon starvation (Figure 4A, D), we
postulated that perhaps the p53- and ERK7-dependent ribosome
surveillance response contributes to dILP accumulation in the
IPCs upon starvation. This proved to be the case, as inhibition of
either p53 (Figure 7A, B; Figure S10) or ERK7 (Figure 7C, D) in
the IPCs partially reduced the accumulation of dILP2 following
starvation of the larvae. While we cannot rule out the possibility
that the knockdown of p53 and ERK7 affects dILP2 translation in
this setting, the most parsimonious explanation is that p53 and
ERK7 contribute to dILP2 secretion upon starvation.
Discussion
Here we report a novel cell-autonomous control mechanism for
dILP secretion. Specifically, we conclude that i) inhibition of
ribosome biogenesis in the IPCs at any level tested, including
ribosomal gene expression (Myc), ribosome maturation (Rio1,
Rio2, Tsr1) or by introducing imbalance of ribosomal components
(Rpl35A), triggers a response to inhibit dILP secretion, ii) this
inhibitory response is dependent on p53, a known surveillance
factor for ribosome biogenesis, iii) a downstream effector of this
ribosome surveillance pathway is protein kinase ERK7, as erk7
mRNA levels are elevated upon inhibited ribosome biogenesis and
p53 activation and erk7 is essential to inhibit dILP secretion in
both conditions, iv) the ribosome surveillance mechanism discov-
ered here likely contributes to starvation-induced inhibition of
dILP secretion. These findings significantly broaden the view
about the regulatory functions of the ribosome surveillance
pathways, which have been mainly explored at the level of
proliferating cells. Ribosome biogenesis serves as the key
determinant of cell autonomous growth control and it is finely
tuned to match with the cellular nutrient and energy status [1,12].
Coupling dILP secretion to the ribosome biogenesis pathway is an
elegant mechanism for multicellular animals to synchronize the
hormonal growth control with the local cell autonomous
regulation of growth. Comparable to our finding in the IPCs,
inhibition of ribosome biogenesis in the fat body leads to a block of
dILP secretion in the IPCs through an unknown humoral
mechanism [22,24,39]. Linking ribosome biogenesis to growth
control through parallel mechanisms likely provides a robust
regulatory network to tune down systemic growth signals
whenever any region of the body experiences nutrient deprivation.
This synchronization is likely important to maintain balanced
growth throughout the spectrum of dietary conditions. Future
studies should be aimed to explore the possible interrelationship
between the fat body-derived signals and the cell-autonomous
mechanism discovered here.
Our findings highlight that the p53-mediated ribosome
surveillance pathway can serve highly cell type-specific functions
in vivo. This is interesting when considering human ribosomo-
pathies, genetic diseases caused by impaired ribosome biogenesis
Figure 4. erk7 mRNA levels are elevated upon impaired ribosome biogenesis or starvation. (A) ERK7 mRNA levels in the IPCs were
detected by in situ hybridization upon IPC-specific knockdown of Rio2 (dILP2-Gal4) or starvation. (B, C) Quantitative RT-PCR analysis of relative erk7
mRNA expression upon ubiquitous knockdown (Tub-G80TS; Tub-Gal4) of Rio1 and Rio2 (B), or dMyc (C) in whole larvae. (D) Relative erk7 mRNA levels
upon feeding and starvation in whole w1118 larvae. Error bars represent standard deviation (N= 3, $5 larvae/group). actin was used as an internal
reference. *p,0.05, **p,0.01 (Student’s t-test).
doi:10.1371/journal.pgen.1004764.g004
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manifesting with a wide spectrum of tissue-specific defects. One of
the ribosomopathies, Shwachman-Diamond syndrome (SDS), is
manifested with a failure in pancreatic function [20]. A mouse
model of SDS displays general preservation of ductal and
endocrine compartments, but reduced amount of zymogen
granules. Moreover, SDS mutant mice have reduced glucose
tolerance, suggesting compromised endocrine function [40]. It will
be interesting to learn whether p53 and ERK7 act as mediators of
the secretion-related defects observed in SDS.
Compared to other members of the MAP kinase family, ERK7
has remained relatively poorly characterized [41]. Earlier studies
in mammalian and Drosophila cells have shown that ERK7
protein levels are actively regulated at the level of protein
degradation [38,42]. In mammals, an increase in ERK7 levels
leads to autophosphorylation and consequent activation [43,44].
Consistent with the idea that ERK7 is mainly regulated through
abundance, we observed that elevated ERK7 expression had a
prominent impact in the function of IPCs. Interestingly, earlier
studies have linked ERK7 function to growth regulation by
showing that ERK7 protein is stabilized by serum and amino acid
starvation [38]. Our data provides evidence that impaired
ribosome biogenesis as well as starvation increases the expression
of erk7 mRNA revealing a novel regulatory level for ERK7
function. In addition to the conditions explored here, ERK7
expression levels increase towards the end of larval development
when growth is ceased [45]. It will be interesting to learn further
how ERK7 expression is regulated and whether ERK7 has a
function in tissue growth control beyond its role in the IPCs.
Earlier studies in cell culture have shown evidence that ERK7
regulates cancer cell proliferation and autophagy [46,47],
suggesting that ERK7 may have a broader role in the regulation
of tissue growth.
Materials and Methods
Fly stocks and husbandry
RNAi lines were from Vienna Drosophila RNAi Center
(VDRC), Bloomington Drosophila Stock Center (BDSC) and
National Institute of Genetics (NIG), Japan. Identities of RNAi
lines and transgenes are listed in Table S2. Driver lines used:
dILP2-Gal4, UAS-GFP [4] for all IPC specific experiments, Tub-
G80TS; Tub-Gal4 (temperature sensitive ubiquitous driver) for
ubiquitous expression of RNAi. Sgs3-Gal4 (BDSC#6870) was
used for salivary gland specific experiments [32]. w1118 crossed to
Figure 5. ERK7 mediates inhibition of dILP secretion upon disturbed ribosome biogenesis. Overexpression of ERK7 in the IPCs is
sufficient to inhibit dILP2 (A, B) and dILP5 (C, D) secretion. Notably, dILP5 experiment was done together with Rio2 knockdown and the control
dataset is the same as in Figure 2K. Error bars represent standard deviation, (N$10 brains). (E) ERK7 overexpression in the IPCs results in smaller pupal
volume. Error bars represent standard deviation, (N= 3, 10 pupae/group). (F) Overexpression of ERK7 in the IPCs leads to delayed pupation. Notably,
this experiment was done together with Rio2 knockdown and the control dataset is the same as in Figure 2L. Error bars represent standard deviation,
(N = 4, 30 larvae/group). (G, H) Accumulation of dILP2 in the cell bodies of IPCs upon Rio2 depletion is suppressed by simultaneous knockdown of
ERK7. Error bars represent standard deviation (N$10 brains). (I) Knockdown of ERK7 in the IPCs partially suppresses the small pupal size caused by
Rio2 depletion. Error bars represent standard deviation (N= 3, 10 pupae/group). For all confocal images, IPCs are marked by GFP (green) and dILP2 or
dILP5 is shown as red. **p,0.01, ***p,0.001 (Student’s t-test).
doi:10.1371/journal.pgen.1004764.g005
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respective driver lines was used as control in all experiments. For
generating UAS-ERK7-V5-His, ERK7 cDNA was amplified by
PCR from pMT-ERK7-V5-HisB [38], cloned into KpnI site of
the pUAST-attB vector and confirmed by sequencing. The
transgene was directed to the attP landing site at 22A2. Transgenic
flies were constructed by BestGene Inc.
Flies were grown on medium containing agar 0.6% (w/v),
semolina 3.2% (w/v), malt 6.5% (w/v), dry baker’s yeast 1.8% (w/
v), propionic acid 0.7% (v/v) and Nipagin (methylparaben) 2.4%
(v/v). For starvation, third instar larvae were placed on PBS, 1%
sucrose, 0.4% agar for approximately 15 hours.
Drosophila relative weight determination
To normalize variation between vials due to growth conditions,
we determined the relative weight. UAS-RNAi flies were crossed
to dILP2-Gal4, UAS-GFP/CyO flies and progeny were allowed to
develop at 29uC. Four days after adult emergence, male flies were
weighed in groups ($10 flies/group, N$3), using a precision
balance (Mettler). The mean weight of the flies expressing both
dILP2-Gal4 and RNAi was divided by the mean weight of control
flies (not expressing the dILP2-GAL4) from the same vial.
Measurement of pupal volume
UAS-RNAi flies were crossed to dILP2-Gal4, UAS-GFP/Cyo
flies and allowed to lay eggs at +25uC. GFP positive L1 larvae were
collected (30 per vial) 24 hours after egg deposition (AED) and
grown at +29uC until pupation. Length and width of pupae were
measured using ProgRes CapturePro 2.8.8 program (Jenoptik).
Volumes of the pupae were calculated using the following formula:
4/3p(L/2)(W/2)2 (L, length; W, width).
Immunostainings and antibodies
Brains were dissected from 3rd instar wandering larvae, fixed in
4% formaldehyde-PBS for 30 min at RT and washed in PBT buffer
(0.3% Triton X 100 in PBS). Following blocking for 2 h at RT in 5%
bovine serum albumin (BSA)/PBT, samples were incubated with
respective primary antibodies at 4uC o/n. Samples were washed
three times (15 min each) with PBT and incubated with respective
secondary antibodies for 2 h at RT. After three washes in PBT,
brains were mounted in Vectashield Mounting Medium (Vector
laboratories). Fluorescence images were acquired using a Leica TCS
SP5MP SMD FLIM confocal laser scanning microscope. Antibodies
used: rat anti-dILP2 [5], rabbit anti-dILP2 [48], guinea pig anti-
dILP2 (see below), rabbit anti-dILP5 (5), anti-rat Alexa fluor 633
(Invitrogen), anti-rabbit Alexa fluor 633 (Invitrogen) and anti-guinea
pig Alexa fluor 633 (Invitrogen). Confocal images of each IPC cluster
were taken using the same scan and laser power settings. Total signal
from each cluster was quantified using ImageJ software (NIH).
Representative images were cropped and processed identically for all
the samples of every experiment.
dILP2 antibody generation
Two synthetic peptides (PHKRAMPGADSDLDA) and
(AEVRRRTRQRQGI) corresponding to amino acid sequence
Figure 6. ERK7 acts downstream of p53. (A) Overexpression of p53 in the IPCs (dILP2-Gal4) leads to increased erk7mRNA levels as detected by in
situ hybridization. (B, C) Knockdown of ERK7 suppresses dILP2 accumulation following p53 overexpression. Error bars represent standard deviation,
(N$10 brains). (D) Knockdown of ERK7 in the IPCs rescues the small pupal size caused by p53 overexpression. Error bars represent standard deviation
(N= 3, 10 pupae/group). (E) ERK7 depletion in the IPCs partially rescues the developmental delay caused by p53 overexpression. Error bars represent
standard deviation (N= 4, 30 larvae/group). **p,0.01, ***p,0.001 (Student’s t-test).
doi:10.1371/journal.pgen.1004764.g006
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of dILP2 from 49–63 and 102–114 amino acids respectively were
produced by Storkbio Ltd. (Estonia). These peptides were mixed
and used as immunogens to raise polyclonal antibodies in Guinea
pigs by Storkbio Ltd.
RNA extraction
RNA extraction from larval brains: Equal numbers of L1 larvae
were collected and grown at 29uC. 10 brains from third instar non-
wandering larvae (approx. 85 hours AED) were dissected and
RNA was extracted using Nucleospin RNA XS kit (Macherey-
Nagel) according to the manufacturer’s protocol. RNA extraction
from whole larvae: equal numbers of L1 larvae were collected and
grown at 29uC for 72 h prior to harvesting (96 h AED). $5 third
instar larvae per sample in minimum of three replicates were
homogenized and RNA was extracted using Nucleospin RNA II
kit (Macherey-Nagel) according to the manufacturer’s protocol.
Quantitative RT-PCR
RNA was reverse transcribed using RevertAid H Minus First
Strand cDNA Synthesis Kit (Thermo Scientific). qPCR was
performed using Maxima SYBR Green qPCR Master Mix (2X)
(Fermentas) with Light cycler 480 Real-Time PCR System
(Roche). At least three biological replicates were used for each
genotype and at least three technical replicates were used for each
biological replicate. Primers for quantitative RT-PCR are
presented as Table S3.
In situ hybridization
In situ hybridization was performed as described previously
[49]. Briefly, antisense and sense probes were synthetized by T3/
T7 RNA polymerase-dependent in vitro transcription reaction
(Promega) in the presence of digoxigenin-UTP (Roche). Mid-3rd
instar larval tissues were fixed using 4% formaldehyde and they
were hybridized with the labeled probes for 16 h at 55uC. The
hybridization was visualized by using alkaline phosphatase-
conjugated anti-digoxigenin Fab fragments (1:3,000; Roche) in
the presence of NBT and BCIP substrates (Promega).
Primers for the erk7 probes were as follows:
59-TAATACGACTCACTATAGGGCTCAAGAGCGACGC-
ATTCAA-39
59-ATTAACCCTCACTAAAGGGATACTGGTCCACGTC-
GTAGCG-39
Supporting Information
Figure S1 Kinases influencing dILP2 secretion. (A, B) Knock-
down of Adck, Cdk12 or Pkc98E inhibits dILP2 secretion from
IPCs. Error bars represent standard deviation (N$10). IPCs are
labelled by GFP (green) and dILP2 is shown as red. *p,0.05,
**p,0.01 (Student’s t-test).
(TIF)
Figure S2 Rio2 knockdown or overexpression of ERK7 and p53
in the salivary glands does not affect growth. Pupal volumes
following depletion of Rio2 or overexpression of either ERK7 or
p53 in salivary glands using Sgs3-Gal4. Error bars represent
standard deviation (N= 3, 10 pupae/group).
(TIF)
Figure S3 Depletion of Raptor in the IPCs does not inhibit
dILP2 secretion. (A, B) Knockdown Raptor in IPCs does not lead
to significant accumulation of dILP2 in cell bodies of IPCs. Error
bars represent standard deviation (N$10). IPCs are labelled by
GFP (green) and dILP2 is shown as red. ns: p.0.05 (Student’s t-
test).
(TIF)
Figure 7. p53 and ERK7 regulate dILP2 secretion upon starvation. Knockdown of p53 (A, B) or ERK7 (C, D) in the IPCs partially suppresses
dILP2 accumulation upon starvation. Error bars represent standard deviation, (N$10 brains). Third instar non-wandering larvae were starved for 15 h
on PBS, 1% sucrose, 0.4% agar. IPCs are labelled by GFP (green) and dILP2 is shown as red. *p,0.05, **p,0.01, ***p,0.001 (Student’s t-test).
doi:10.1371/journal.pgen.1004764.g007
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Figure S4 p53 overexpression in the IPCs modestly downreg-
ulates dilp2 mRNA. dilp2 mRNA levels from larval brain RNA
were determined using quantitative RT-PCR. Error bars represent
standard deviation (N=3, 10 brains/group). GAPDHwas used as an
internal reference. *p,0.05 (Student’s t-test).
(TIF)
Figure S5 Knockdown of p53 leads to rescue of reduced pupal
volume observed upon Rio1 depletion. Error bars represent
standard deviation, (N= 4, 10 pupae/group). **p,0.01 (Student’s
t-test).
(TIF)
Figure S6 RNAi against firefly Luciferase does not suppress
Rio2-RNAi phenotypes. (A, B) Accumulation of dILP2 in the cell
bodies of IPCs upon Rio2 depletion is not suppressed by RNAi
against firefly Luciferase (not targeting any endogenous gene). Error
bars represent standard deviation (N$10 brains). IPCs are marked
by GFP (green) and dILP2 is shown as red. (C) Luciferase RNAi in
the IPCs does not rescue the small pupal size caused by Rio2
depletion. Error bars represent standard deviation (N=3, 10
pupae/group). ***p,0.001, ns: p.0.05 (Student’s t-test).
(TIF)
Figure S7 Controls for in situ hybridization. Endogenous erk7
mRNA remains undetectable in the brains of fed control animals
(dILP2-Gal4 x w1118), while IPC-specific overexpression of
transgenic erk7 allows detection of strong IPC-specific staining.
erk7 mRNA expression is detected using the antisense probe, but
not using the sense probe (negative control).
(TIF)
Figure S8 Transcription of dilp2 and dilp5 is not affected by
ERK7 overexpression. Transgenic ERK7 was overexpressed using
dILP2-Gal4 driver. dilp2 and dilp5 mRNA levels were determined
from brain RNA samples using quantitative RT-PCR. Error bars
represent standard deviation (N= 3, 10 brains/group). GAPDH
was used as an internal reference. ns: p.0.05 (Student’s t-test).
(TIF)
Figure S9 ERK7 mediates inhibition of dILP2 secretion upon
dMyc depletion. (A, B) Accumulation of dILP2 in the cell bodies
of IPCs upon dMyc knockdown is suppressed by simultaneous
knockdown of ERK7. Error bars represent standard deviation
(N$10 brains). IPCs are marked by GFP (green) and dILP2 is
shown as red. ***p,0.001 (Student’s t-test).
(TIF)
Figure S10 p53 contributes to regulation of dILP2 secretion
upon starvation. (A, B) Expression of dominant negative p53 in
the IPCs suppresses dILP2 accumulation following starvation.
Error bars represent standard deviation, (N$10 brains). **p,
0.01, ***p,0.001 (Student’s t-test).
(TIF)
Table S1 Primary screening data of the kinome-wide screen
with RNAi expressed specifically in the IPCs.
(XLSX)
Table S2 Identities of RNAi lines and transgenes used in the
study.
(XLSX)
Table S3 Sequences of primers used in the quantitative RT-
PCR experiments.
(DOCX)
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